A Clinical Study of Regorafenib in Participants Who Have Been Treated in Previous Bayer-sponsored Regorafenib Studies That Have Been Completed
Clinical trial NCT03890731 · COMPLETED
Trial details
- NCT number
- NCT03890731
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-02
- Primary completion
- 2023-02-28
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.